ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Mar 20, 2024 | Option Exercise | $18.56 | 20,000 | 371,200 | 99,235 | Mar 22, 2024, 04:12 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Mar 11, 2024 | Sale | $65.21 | 20,565 | 1,341,123 | 1,056,333 | Mar 11, 2024, 08:33 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Mar 07, 2024 | Sale | $66.50 | 40,712 | 2,707,277 | 1,059,063 | Mar 11, 2024, 08:33 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance, CFO | Mar 07, 2024 | Sale | $66.60 | 13,132 | 874,560 | 6,618 | Mar 11, 2024, 08:33 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance, CFO | Mar 10, 2024 | Option Exercise | $56.73 | 4,539 | 257,497 | 4,539 | Mar 11, 2024, 08:33 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance, CFO | Mar 11, 2024 | Sale | $65.96 | 10,121 | 667,587 | 1,129 | Mar 11, 2024, 08:33 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Mar 07, 2024 | Sale | $66.15 | 13,132 | 868,698 | 220 | Mar 11, 2024, 08:32 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Mar 11, 2024 | Sale | $65.97 | 7,345 | 484,537 | 1,238 | Mar 11, 2024, 08:32 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Mar 07, 2024 | Sale | $66.57 | 13,132 | 874,179 | 34,196 | Mar 11, 2024, 08:31 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Mar 11, 2024 | Sale | $65.61 | 7,345 | 481,931 | 32,742 | Mar 11, 2024, 08:31 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 07, 2024 | Sale | $66.56 | 6,450 | 429,308 | 18,892 | Mar 11, 2024, 08:31 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 11, 2024 | Sale | $65.59 | 3,712 | 243,482 | 21,336 | Mar 11, 2024, 08:31 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Feb 27, 2024 | Option Exercise | $45.75 | 40,000 | 1,829,850 | 29,611 | Feb 28, 2024, 07:41 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Feb 26, 2024 | Sale | $69.53 | 7,907 | 549,784 | 7,607 | Feb 27, 2024, 08:00 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance, CFO | Feb 26, 2024 | Sale | $59.47 | 19,219 | 1,142,948 | 7,155 | Feb 27, 2024, 08:00 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Feb 26, 2024 | Sale | $69.79 | 22,590 | 1,576,464 | 1,072,299 | Feb 27, 2024, 07:59 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Feb 26, 2024 | Sale | $70.17 | 4,112 | 288,534 | 12,200 | Feb 27, 2024, 07:58 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Feb 26, 2024 | Sale | $70.13 | 7,907 | 554,491 | 37,407 | Feb 27, 2024, 07:58 PM |
ITCI | | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Director | Feb 26, 2024 | Sale | $57.18 | 63,085 | 3,606,932 | 65,990 | Feb 27, 2024, 07:57 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Feb 02, 2024 | Sale | $66.42 | 11,860 | 787,719 | 714 | Feb 05, 2024, 06:13 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Feb 02, 2024 | Sale | $67.07 | 33,885 | 2,272,693 | 1,067,759 | Feb 05, 2024, 06:10 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Feb 02, 2024 | Sale | $67.15 | 11,860 | 796,367 | 36,604 | Feb 05, 2024, 06:07 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance, CFO | Feb 02, 2024 | Sale | $66.62 | 11,183 | 745,037 | 185 | Feb 05, 2024, 06:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Feb 02, 2024 | Sale | $67.19 | 6,167 | 414,355 | 9,540 | Feb 05, 2024, 06:02 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Jan 17, 2024 | Sale | $41.55 | 96,168 | 3,995,758 | 1,098,393 | Jan 18, 2024, 07:47 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Jan 18, 2024 | Sale | $41.03 | 135,834 | 5,572,929 | 1,118,226 | Jan 18, 2024, 07:47 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Jan 16, 2024 | Sale | $42.05 | 150,722 | 6,338,569 | 1,125,670 | Jan 18, 2024, 07:47 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Jan 11, 2024 | Sale | $40.22 | 100,000 | 4,021,749 | 50,000 | Jan 12, 2024, 06:02 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Jan 02, 2024 | Sale | $45.24 | 124,564 | 5,634,656 | 62,282 | Jan 04, 2024, 07:54 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Dec 31, 2023 | Option Exercise | $71.62 | 251 | 17,977 | 79,235 | Jan 03, 2024, 06:46 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Dec 31, 2023 | Option Exercise | $71.62 | 76 | 5,443 | 9,611 | Jan 03, 2024, 06:43 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Dec 13, 2023 | Sale | $65.00 | 21,262 | 1,382,030 | 0 | Dec 15, 2023, 05:01 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Nov 13, 2023 | Sale | $33.73 | 100,000 | 3,372,832 | 50,000 | Nov 14, 2023, 05:33 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Nov 06, 2023 | Sale | $43.37 | 69,147 | 2,998,642 | 72,093 | Nov 08, 2023, 05:31 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Sep 30, 2023 | Option Exercise | $52.09 | 105 | 5,469 | 9,535 | Oct 02, 2023, 05:30 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Sep 30, 2023 | Option Exercise | $52.09 | 345 | 17,971 | 78,984 | Oct 02, 2023, 05:29 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Sep 18, 2023 | Sale | $53.76 | 55,587 | 2,988,213 | 1,122,841 | Sep 19, 2023, 08:40 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Sep 19, 2023 | Sale | $54.17 | 44,413 | 2,405,852 | 1,050,309 | Sep 19, 2023, 08:40 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Aug 07, 2023 | Option Exercise | $38.69 | 110,600 | 4,279,114 | 100,639 | Aug 09, 2023, 06:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Jul 17, 2023 | Sale | $65.00 | 1,842 | 119,730 | 21,262 | Jul 20, 2023, 05:47 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Jun 30, 2023 | Option Exercise | $63.32 | 85 | 5,382 | 9,430 | Jul 05, 2023, 04:29 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Jun 14, 2023 | Sale | $53.14 | 163,708 | 8,698,647 | 81,854 | Jun 16, 2023, 05:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Apr 17, 2023 | Sale | $38.03 | 20,000 | 760,500 | 19,345 | Apr 19, 2023, 06:00 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Mar 31, 2023 | Option Exercise | $54.15 | 313 | 16,949 | 78,360 | Apr 04, 2023, 05:01 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Mar 28, 2023 | Sale | $54.31 | 15,604 | 847,380 | 55,522 | Mar 30, 2023, 05:08 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 13, 2023 | Sale | $45.04 | 7,344 | 330,794 | 23,450 | Mar 13, 2023, 07:36 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Mar 13, 2023 | Sale | $44.98 | 3,758 | 169,042 | 61,366 | Mar 13, 2023, 07:35 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Mar 10, 2023 | Sale | $43.34 | 8,550 | 370,557 | 59,157 | Mar 13, 2023, 07:35 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Mar 10, 2023 | Sale | $43.10 | 16,708 | 720,086 | 2,500 | Mar 13, 2023, 07:34 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Mar 13, 2023 | Sale | $44.94 | 7,344 | 330,007 | 476 | Mar 13, 2023, 07:34 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Mar 10, 2023 | Sale | $43.06 | 15,663 | 674,417 | 2,700 | Mar 13, 2023, 07:32 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Mar 13, 2023 | Sale | $44.93 | 5,582 | 250,808 | 258 | Mar 13, 2023, 07:32 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Mar 10, 2023 | Sale | $43.15 | 41,770 | 1,802,566 | 1,137,114 | Mar 13, 2023, 07:31 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Mar 13, 2023 | Option Exercise | $24.42 | 40,565 | 990,475 | 1,150,309 | Mar 13, 2023, 07:31 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Mar 01, 2023 | Sale | $50.01 | 7,241 | 362,122 | 49,199 | Mar 03, 2023, 07:03 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Feb 24, 2023 | Sale | $47.12 | 4,046 | 190,648 | 56,440 | Feb 27, 2023, 08:03 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | SVP, Chief Medical Officer | Feb 24, 2023 | Sale | $47.14 | 7,906 | 372,689 | 23,104 | Feb 27, 2023, 08:02 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Feb 24, 2023 | Sale | $47.03 | 7,906 | 371,819 | 0 | Feb 27, 2023, 08:01 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Feb 24, 2023 | Sale | $47.03 | 7,455 | 350,609 | 0 | Feb 27, 2023, 08:00 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Feb 24, 2023 | Sale | $22.06 | 52,590 | 1,160,208 | 1,130,309 | Feb 27, 2023, 07:59 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Feb 21, 2023 | Sale | $47.01 | 3,898 | 183,246 | 53,338 | Feb 22, 2023, 08:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | SVP, Chief Medical Officer | Feb 21, 2023 | Sale | $46.84 | 8,354 | 391,304 | 24,785 | Feb 22, 2023, 08:04 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Feb 21, 2023 | Sale | $46.84 | 11,139 | 521,699 | 1,843 | Feb 22, 2023, 08:03 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Feb 17, 2023 | Sale | $31.28 | 107,936 | 3,376,476 | 53,968 | Feb 22, 2023, 08:02 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Feb 21, 2023 | Sale | $46.82 | 10,443 | 488,891 | 1,794 | Feb 22, 2023, 08:02 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Feb 21, 2023 | Sale | $46.83 | 27,848 | 1,304,000 | 1,105,262 | Feb 22, 2023, 08:01 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Dec 30, 2022 | Option Exercise | $52.92 | 97 | 5,133 | 9,250 | Jan 03, 2023, 04:19 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Dec 30, 2022 | Option Exercise | $52.92 | 321 | 16,987 | 78,047 | Jan 03, 2023, 04:18 PM |
ITCI | | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Director | Dec 19, 2022 | Sale | $50.82 | 5,000 | 254,100 | 29,233 | Dec 21, 2022, 04:06 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Dec 13, 2022 | Sale | $55.00 | 33,083 | 1,819,565 | 1,100,309 | Dec 15, 2022, 07:01 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Dec 01, 2022 | Sale | $34.60 | 100,000 | 3,460,014 | 50,000 | Dec 02, 2022, 07:14 PM |
ITCI | | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Director | Nov 07, 2022 | Sale | $52.30 | 10,000 | 523,023 | 39,233 | Nov 08, 2022, 04:12 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Sep 30, 2022 | Option Exercise | $46.53 | 110 | 5,118 | 9,153 | Oct 05, 2022, 04:04 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Sep 30, 2022 | Option Exercise | $46.53 | 365 | 16,983 | 77,726 | Oct 04, 2022, 04:11 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Sep 21, 2022 | Sale | $30.55 | 130,328 | 3,981,493 | 65,164 | Sep 23, 2022, 09:01 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Aug 11, 2022 | Sale | $34.89 | 60,000 | 2,093,475 | 39,043 | Aug 12, 2022, 06:09 PM |
ITCI | | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Director | Aug 11, 2022 | Sale | $59.22 | 10,000 | 592,200 | 44,233 | Aug 12, 2022, 06:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Jun 30, 2022 | Option Exercise | $57.08 | 289 | 16,496 | 77,361 | Jul 05, 2022, 04:06 PM |
ITCI | | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Director | May 12, 2022 | Sale | $55.00 | 10,000 | 550,000 | 54,233 | May 13, 2022, 05:24 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Apr 08, 2022 | Sale | $38.55 | 172,696 | 6,657,261 | 131,687 | Apr 08, 2022, 06:56 PM |
ITCI | | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBERT L | Director | Mar 31, 2022 | Option Exercise | $61.19 | 126 | 7,710 | 8,935 | Apr 04, 2022, 04:11 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Mar 31, 2022 | Option Exercise | $61.19 | 257 | 15,726 | 77,072 | Apr 04, 2022, 04:08 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Mar 17, 2022 | Sale | $60.33 | 141,499 | 8,536,646 | 135,549 | Mar 18, 2022, 08:12 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Mar 18, 2022 | Sale | $61.18 | 20,637 | 1,262,505 | 15,736 | Mar 18, 2022, 08:12 PM |
ITCI | | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Director | Mar 16, 2022 | Sale | $59.27 | 64,534 | 3,824,827 | 205,984 | Mar 18, 2022, 08:12 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Mar 09, 2022 | Option Exercise | $2.84 | 38,925 | 110,547 | 1,133,392 | Mar 10, 2022, 04:13 PM |
ITCI | | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Director | Mar 07, 2022 | Sale | $54.52 | 5,000 | 272,600 | 43,980 | Mar 09, 2022, 09:49 PM |
ITCI | | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Director | Mar 08, 2022 | Sale | $52.68 | 15,000 | 790,150 | 38,980 | Mar 09, 2022, 09:49 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Mar 04, 2022 | Sale | $55.52 | 3,860 | 214,307 | 23,104 | Mar 04, 2022, 06:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Mar 02, 2022 | Sale | $56.98 | 4,177 | 238,005 | 26,964 | Mar 04, 2022, 06:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Feb 24, 2022 | Sale | $52.27 | 4,046 | 211,468 | 33,984 | Feb 25, 2022, 07:09 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Feb 24, 2022 | Sale | $52.21 | 7,906 | 412,810 | 50,585 | Feb 25, 2022, 07:08 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Feb 24, 2022 | Sale | $51.98 | 7,906 | 410,933 | 4,188 | Feb 25, 2022, 07:06 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Feb 24, 2022 | Sale | $51.97 | 7,454 | 387,349 | 4,083 | Feb 25, 2022, 07:04 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Feb 24, 2022 | Sale | $51.98 | 22,589 | 1,174,074 | 1,105,807 | Feb 25, 2022, 07:01 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Feb 22, 2022 | Sale | $55.29 | 4,177 | 230,958 | 28,638 | Feb 23, 2022, 07:08 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Feb 22, 2022 | Sale | $55.29 | 11,139 | 615,827 | 49,946 | Feb 23, 2022, 07:07 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | Feb 22, 2022 | Sale | $55.40 | 11,139 | 617,100 | 4,550 | Feb 23, 2022, 07:05 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | Feb 22, 2022 | Sale | $55.40 | 10,443 | 578,506 | 4,627 | Feb 23, 2022, 07:02 PM |
ITCI | | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | Feb 22, 2022 | Sale | $55.39 | 27,847 | 1,542,413 | 1,107,134 | Feb 23, 2022, 07:00 PM |